Depression positively associated with recovered, incident and persistent Metabolic Syndrome

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-01-27 04:45 GMT   |   Update On 2023-01-27 07:12 GMT

Researchers have found in a new study that Depression is positively associated with recovered, incident and persistent Metabolic Syndrome (MetS).The study has been published in Journal of Psychiatric Research.Metabolic Syndrome (MetS) and depression comorbidity has been recognized, but its directionality is still uncertain. The aims of this study was to assess the association between...

Login or Register to read the full article

Researchers have found in a new study that Depression is positively associated with recovered, incident and persistent Metabolic Syndrome (MetS).

The study has been published in Journal of Psychiatric Research.

Metabolic Syndrome (MetS) and depression comorbidity has been recognized, but its directionality is still uncertain.

The aims of this study was to assess the association between depression (diagnosis and severity) and MetS (components, diagnosis and trajectory) in the baseline and over a 4-year follow-up period. Material and methods: Baseline and follow-up data from 13,883 participants of the Brazilian Longitudinal Study of Adult Health were analyzed. The Clinical Interview Schedule Revised assessed depressive episode and its severity. MetS components and diagnosis were assessed according to the National Cholesterol Education Program Adult Treatment Panel III. Participants were grouped according to MetS trajectory as recovered, incident and persistent MetS. Logistic regression analysis was conducted estimating odds ratios (OR) and 95% confidence intervals (95%CI). Results:

• Baseline depression was positively associated with recovered, incident and persistent MetS. Baseline depression was also associated with large waist circumference, high triglycerides, low high-density lipoprotein cholesterol, and hyperglycemia at follow-up.

• Having three or more MetS components at follow-up was associated with baseline depression, with a positive dose-response effect

• The magnitude of associations was greater in severe depression, when compared to moderate and mild.

These results support that depression is a risk factor for the development of MetS and highlights the need to follow metabolic and cardiovascular alterations in the presence of depression.

Reference:

Lara Onofre Ferriani, Daniela Alves Silva, Maria del Carmen Bisi Molina, José Geraldo Mill, André Russowsky Brunoni, Maria de Jesus Mendes da Fonseca, Arlinda B. Moreno, Isabela M. Benseñor, Odaleia Barbosa de Aguiar, Sandhi Maria Barreto, Maria Carmen Viana,

Depression is a risk factor for metabolic syndrome: Results from the ELSA-Brasil cohort study. Journal of Psychiatric Research, Volume 158, 2023, Pages 56-62, ISSN 0022-3956,https://doi.org/10.1016/j.jpsychires.2022.12.017.

Tags:    
Article Source : Journal of Psychiatric Research

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News